Nemysis Patents – Insights & Stats (Updated 2023)

Nemysis has a total of 30 patents globally, out of which 11 have been granted. Of these 30 patents, more than 80% patents are active. Italy, Europe (EPO), United States of America is where Nemysis has filed the maximum number of patents. Parallelly, Italy seems to be the main focused R&D centre and also Ireland is the origin country of Nemysis.

Nemysis was founded in 2015. Operator specializes in addressing nutritional disorders with novel products: a gastric-resistant glutenous for celiac disease therapy, and an iron supplement with a gluten-destroying medical device, preventing symptoms in celiac and gluten-sensitive patients, reducing gastrointestinal side effects during iron supplementation.

Do read about some of the most popular patents of Nemysis which have been covered by us in this article and also you can find Nemysis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Nemysis patent portfolio.

How many patents does Nemysis have?

Nemysis has a total of 30 patents globally. These patents belong to 10 unique patent families. Out of 30 patents, 24 patents are active.

How Many Patents did Nemysis File Every Year?

Nemysis Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantNemysis Applications FiledNemysis Patents Granted
20231
202231
202132
202082
201912
20183
201621
201511
20141

How many Nemysis patents are Alive/Dead?

Worldwide Patents

Nemysis Patent Portfolio

How Many Patents did Nemysis File in Different Countries?

Nemysis Worldwide Patent Filing

Countries in which Nemysis Filed Patents

CountryPatent
Italy3
Europe (EPO)3
United States of America3
Brazil2
China2
Canada2
India2
United Kingdom1
Spain1
Australia1
Denmark1
Turkey1
Japan1
Hong Kong (S.A.R.)1
Portugal1
Russian Federation1

Where are Research Centers of Nemysis Patents Located?

R&D Centres of Nemysis

What Percentage of Nemysis US Patent Applications Were Granted?

Nemysis (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.

Below are the key stats of Nemysis patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Nemysis?

Law FirmTotal ApplicationsSuccess Rate
Mcneill Baur Pllc10%
Silvia Salvadori PC10%
Stetina Brunda Garred & Brucker1100.00%

List of Nemysis patents

Nemysis PatentsTitle
US10709787B2Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease
US20230134391A1Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases
US20220364069A1Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase
EP3139961B1Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease
EP4132506A1Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases
EP4004199A1Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase
CN106488772BHydrogel Of Methacrylic Acid Hyaluronic Acid Derivative For Oral Enzyme Therapy Of Celiac
CN114174519AMethod For Producing An Enzyme Composition Comprising A Recombinant Endopeptidase
WO2023285135A1New Systems For Producing Recombinant Proteins
WO2021204705A1Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases
WO2021013553A1Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase
CA2946811CHydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease
CA3143903A1Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase
AU2020318422A1Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase
JP06532483B2Hydrogel Of The Methacryl Hyaluronic Acid Derivative For The Oral Enzyme Treatment Of The Celiac Disease
IN365053BHydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease
RU2679638C2Hydrogels Of Methacryl Derivatives Of Hyaluronic Acid For Oral Enzymatic Therapy Of Gluten Enteropathy
DK3139961T3Hydrogels Of Methacryl Hyaluronic Acid Derivatives For Oral Enzymy Therapy
ES2675574T3Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease
IT2019000012942B1Method For The Production Of An Enzymatic Composition Including A Recombinant Endopeptidase
IT1423638B1Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease.
IN202024004527AMethod For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase
BR112022000954A2A Method For Producing An Enzyme Composition Comprising A Recombinant Endopeptidase
BR112016026039A2Hydrogels Of Methacrylic Derivatives Of Hyaluronic Acid For Enzymatic Oral Therapy Of A Celiac Disease
HK40087350ACarboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases
IT202100018254A1New Systems For Producing Recombinant Proteins
PT3139961THydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease
TR201809421T4Hydrojels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease.
WO2015169849A1Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease
GB202005054D0Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases

What are Nemysis key innovation segments?

What Technologies are Covered by Nemysis?

The chart below distributes patents filed by Nemysis in different countries on the basis of the technology protected in patents. It also represents the markets where Nemysis thinks it’s important to protect particular technology inventions.

R&D Focus: How has Nemysis search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Nemysis?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.